Intervention not reported
True negatives
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
False positives
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Test result
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
True positives
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
False negatives
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
True negatives
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Fatigue · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Fatigue · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Fatigue · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Overall survival: BRCA1 or BRCA2
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes overall survival: BRCA1 or BRCA2 compared with no RRSO (very low certainty).
1 finding from 1 review
HGSC mortality: BRCA1 only
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes HGSC mortality: BRCA1 only compared with no RRSO according to BRCA mutation status (very low certainty).
1 finding from 1 review
HGSC mortality: BRCA2 only
1 finding from 1 review
Breast cancer mortality: BRCA1 only
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes breast cancer mortality: BRCA1 only compared with no RRSO according to BRCA mutation status (very low certainty).
1 finding from 1 review
Breast cancer mortality: BRCA2 only
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes breast cancer mortality: BRCA2 only compared with no RRSO according to BRCA mutation status (very low certainty).
1 finding from 1 review
Quality of life (ovarian cancer risk perception): BRCA1 only
1 finding from 1 review